The present invention relates to a pharmaceutical co-crystal comprising an active pharmaceutical ingredient and a co-crystal agent having the structure R1-C(=O)XH.La présente invention concerne des co-cristaux pharmaceutiques comprenant un ingrédient pharmaceutique actif et un agent co-cristal ayant la structure R1-C(=O)XH.